Скачайте изображение (превью) выбрав качество

320x180 480x360 640x480 1280x720

Watch the full video on Radcliffe Cardiology:

In this interview, Professor Adrian Banning (John Radcliffe Hospital, Oxford, UK) discusses the five-year outcomes of the SYNTAX II trial. This study aims to evaluate the impact of new technologies in percutaneous coronary intervention (PCI) by comparing the outcomes of these procedures to the original SYNTAX trial. The study showed that PCI moved forward considerably in the last 5 years, it is safer and it is competitive with surgery.

Questions
1. What is the reasoning behind this trial? What were the main developments in PCI in recent years?
2. What are your key findings at five years?
3. How should your findings impact practice and clinical decision-making?
4. What are the take-home messages?

Recorded remotely from Oxford, 2021.

Interviewer: Jordan Rance
Editor: Mirjam Boros

Radcliffe Cardiology is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide. We aim to assist in the continuous education of physicians within the cardiology fraternity, generating a range of clinical content through collaboration with leading cardiologists from around the globe.

Чтобы скачать видео "SYNTAX II Trial: 5yr Data Shows Reduction in MACE in PCI | Prof Adrian Banning" передвинте ползунок вправо